Sangamo Therapeutics, Inc.
(NASDAQ : SGMO)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Are you a Dividend Trader
Learn how to make passive income from the best dividend stocks.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
AMGNAmgen Inc.
1.12%178.041.3%$463.27m
CELGCelgene Corporation
0.98%97.461.3%$422.24m
GILDGilead Sciences, Inc.
1.29%67.220.9%$393.54m
BIIBBiogen Inc.
2.11%232.481.3%$354.87m
ILMNIllumina, Inc.
1.67%349.733.5%$272.41m
REGNRegeneron Pharmaceuticals, Inc.
2.30%312.272.6%$234.26m
AAgilent Technologies, Inc.
0.80%70.531.6%$213.77m
VRTXVertex Pharmaceuticals Incorporated
2.15%173.871.9%$198.35m
ARRYArray BioPharma Inc.
56.58%46.338.2%$185.61m
EXASExact Sciences Corporation
1.02%110.9025.3%$184.74m
ALXNAlexion Pharmaceuticals, Inc.
2.53%120.912.0%$176.51m
BMRNBioMarin Pharmaceutical Inc.
4.39%84.394.3%$136.55m
MRTXMirati Therapeutics Inc.
6.48%100.372.5%$113.95m
IONSIonis Pharmaceuticals, Inc.
4.11%64.648.2%$96.92m
INCYIncyte Corporation
5.51%81.992.5%$92.11m

Company Profile

Sangamo Therapeutics, Inc. engages in researching and developing transcription factors in the regulation of genes. It focuses on the research, development and commercialization of engineered DNA-binding proteins for therapeutic genome editing and gene regulation technology platform is enabled by the engineering of a class of transcription factors known as zinc finger DNA-binding proteins. The company was founded by Edward O. Lanphier II in 1995 and is headquartered in Richmond, CA.